KY lung cancer patient, Leah, doesn’t qualify for early detection screening, so when she was diagnosed with stage IV lung cancer due to a mutation research for treatments to target her EGFR mutation became her greatest HOPE for more LIFE w/ her kids & husband! #anyonewithlungs

Thank you for shedding light on the #2 cause of lung cancer & #1 cause in those who’ve never smoked. We must better understand the role toxins & genetics play in this deadly disease to diagnose, treat, and improve survival outcomes for all patients. #anyonewithlungs

This disease may have one name but does not have just one cause! More research is needed to educate, recognize, & identify other risk factors & develop methods for early detection & diagnosis of more patients who are also at risk, regardless of smoking history. #anyonewithlungs

Brittany is a young mom who deserves an opportunity to live!!

This is my friend Brittany who also happens to have stage IV lung cancer as a never smoker. She was born and raised in Kentucky. She has a husband and son who love here dearly. Please help spread the word.

We lift up this tribute to the RETpositive community. Their patient population may be small but their visibility is equally important. Continued research & more treatment options will help them keep LIVING with lung cancer. #YLCI #Visibility4Us #RETPositive

This is a great read!

This!!!

1/ 📢Young-onset #lungcancer is a rising concern, with epidemiological trends showing 📈 incidence. 📢Early detection and individualized, targeted treatments are key to achieving superior outcomes. 📢Ready for a deep dive into #YoungLungCancer? Let’s go!

2/ 🫁💡Patients with #YoungLungCancer are a distinct subgroup. In a cohort of young NSCLC  patients <50 years, two-thirds of patients presented at advanced clinical stage (67% at Stage IV). 🫁💡🔗: Hughes et al ncbi.nlm.nih.gov/pmc/articles/P…

Young Lung Cancer Initiative 5/ 🫁Lower survival indices have been noted in #younglungcancer 🫁Shi et al noted 1, 3, & 5-year #OS for pts <45years of 68.58%, 36.86% and 27.14% compared to ⬆️rates: 75.11%, 41.83% and 30.82% in older pts. HR - 0.829 (95% CI 0.747, 0.920) 🔗: nature.com/articles/s4159…

Narjust Florez, MD, FASCO #FlorezLab 7/ 🫁💡Pts with lung cancer often have ⬆️ rates of depression & anxiety. Gender differences in coping mechanisms also exist. 🫁💡A study by Florez et al. places emphasis on integrated supportive care in addressing mental health and improving #QOL 🔗:clinical-lung-cancer.com/article/S1525-…

Narjust Florez, MD, FASCO #FlorezLab Leah’s delayed diagnosis story. If she had not persisted… who knows how long it would have taken to get a diagnosis!

It's personal because we live it, we experience loss from it, we fear it, we question it, we hate it...but most of all - we JUST want to LIVE despite it! #younglungcancer @florez_Lab@ EGFR Resisters ALK Positive Narjust Florez, MD, FASCO Oncogene Cancer Research RETpositive

#FlorezLab

I fall in this category!!! It took 3 months to get my stage IV lung cancer diagnosis. Prior to my official diagnosis I was diagnosed with post viral cough, exercise induced asthma, pneumonia, etc. Totally unacceptable!

Wow-5yr PFS data from CROWN (1L lorlatinib v crizotinib in ALK+ NSCLC) is undeniable! Is this enough to recommend 1L lorlatinib to ALL patients? How to factor in patient preference & toxicity? Management of lorlatinib AEs in Clinical Lung Cancer: lungcancerjournal.info/article/S0169-… #ASCO24

Let’s talk Young Lung Cancer at #ASCO24 Young Lung Cancer Initiative

This is one of the very passionate doctors who are helping to bring awareness to young lung cancer. He is rocking one of our Young Lung Cancer Initiative shirts!

Just listened to my friend Samantha M on the ⁦⁦Young Lung Cancer Initiative⁩ podcast. Great talk about stage 4 HER2+ lung cancer. As researchers, we focus on protein-protein interactions. Important reminder about the impact of person-person interactions! youtu.be/WZDdg8j3pO8?si…